Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

Author(s): Hans Carl Hasselbalch

Volume 12, Issue 3, 2011

Page: [387 - 391] Pages: 5

DOI: 10.2174/138945011794815220

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

28

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Pharmacokinetic Properties of Rituximab
Reviews on Recent Clinical Trials

Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data
Current Drug Safety

Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews

A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Recent Patents on Anti-Cancer Drug Discovery

Insights into the Role of mTOR/AMPK as a Potential Target for Anticancer Therapy
Current Drug Therapy

The Anti-Cancer Activity of Noscapine: A Review
Recent Patents on Anti-Cancer Drug Discovery

Application of Transcriptome Analysis to Clinical Pharmacology Studies
Current Molecular Medicine

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Current Pharmaceutical Design

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
Current Cancer Drug Targets

Microgravity Alters Cancer Growth and Progression
Current Cancer Drug Targets

3D-QSAR Studies of HDAC6 Inhibitors Using Docking-Based Alignment
Letters in Drug Design & Discovery

A Case of Ischemic Stroke in Acute Promyelocytic Leukemia at Initial Presentation: Relevance of All-Trans Retinoic Acid Treatment
Cardiovascular & Hematological Disorders-Drug Targets

Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.
Current Pharmaceutical Biotechnology

Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art
Current Drug Targets

Preclinical and Clinical Studies on the Use of Platinum Complexes for Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry

miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
Anti-Cancer Agents in Medicinal Chemistry

Erythropoietin in Cancer: An Update
Current Molecular Medicine

Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
Current Cancer Drug Targets

Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs
Current Medicinal Chemistry

© 2025 Bentham Science Publishers | Privacy Policy